Literature DB >> 11731604

Let the consumer decide? The regulation of commercial genetic testing.

D M Levitt1.   

Abstract

OBJECTIVES: The development of predictive genetic tests provides a new area where consumers can gain knowledge of their health status and commercial opportunities. "Over-the-counter" or mail order genetic tests are most likely to provide information on carrier status or the risk of developing a multifactorial disease. The paper considers the social and ethical implications of individuals purchasing genetic tests and whether genetic information is different from other types of health information which individuals can obtain for themselves.
DESIGN: The discussion is illustrated by findings from a questionnaire survey of university students as potential consumers. Topics covered included what health tests they had already used, expectations of genetic tests, willingness to pay, who should have access to the results and whether there need to be restrictions on such tests. SAMPLE-Six hundred and fifteen first-year students in the universities of Leuven, Cardiff, Central Lancashire, Vienna and Nijmegen studying either medicine or a non-science subject.
RESULTS: Students were enthusiastic about genetic tests and had high expectations of their accuracy and usefulness but most thought they should be available through the health service and a minority thought that some tests, for example for sex selection, should not be available at all. There were few differences in responses by sex or subject of study but some by country. The paper also considers ethical and social issues outside the scope of a questionnaire survey of this type.
CONCLUSION: To address some of these issues the sale of genetic tests to individuals can be made subject to ethical guidelines or codes of practice, for example to protect vulnerable groups, but there are fundamental social and ethical questions which such guidelines cannot address.

Mesh:

Year:  2001        PMID: 11731604      PMCID: PMC1733464          DOI: 10.1136/jme.27.6.398

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  6 in total

1.  Drawing the line: an analysis of lay people's discussions about the new genetics.

Authors:  Anne Kerr; Sarah Cunningham-Burley; Amanda Amos
Journal:  Public Underst Sci       Date:  1998-04

2.  The ethical implications of antenatal screening for Down's syndrome: Socratic inquiry; The good life?; Calculating the costs and benefits.

Authors:  Chris Goodey; Priscilla Alderson; John Appleby
Journal:  Bull Med Ethics       Date:  1999-04

Review 3.  The case against childhood cholesterol screening.

Authors:  T B Newman; W S Browner; S B Hulley
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

4.  Disclosure of Duchenne muscular dystrophy after newborn screening.

Authors:  E Parsons; D Bradley; A Clarke
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

5.  'No consensus' on FDA role in gene tests.

Authors:  M Wadman
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

6.  GIG response to the UK Clinical Genetics Society report "The genetic testing of children".

Authors:  S Dalby
Journal:  J Med Genet       Date:  1995-06       Impact factor: 6.318

  6 in total
  10 in total

1.  Overcritical, overfriendly? A dialogue between a sociologist and a philosopher on genetic technology and its applications.

Authors:  Mairi Levitt; Matti Häyry
Journal:  Med Health Care Philos       Date:  2005

Review 2.  Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy.

Authors:  Ludvig Beckman
Journal:  Theor Med Bioeth       Date:  2004

3.  Patient autonomy and choice in healthcare: self-testing devices as a case in point.

Authors:  Anna-Marie Greaney; Dónal P O'Mathúna; P Anne Scott
Journal:  Med Health Care Philos       Date:  2012-11

4.  Attitudes of healthcare professionals and parents regarding genetic testing for violent traits in childhood.

Authors:  E Campbell; L F Ross
Journal:  J Med Ethics       Date:  2004-12       Impact factor: 2.903

5.  Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Authors:  Stacy W Gray; Cristin O'Grady; Lauren Karp; Daniel Smith; J Sanford Schwartz; Robert C Hornik; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

6.  A novel, privacy-preserving cryptographic approach for sharing sequencing data.

Authors:  Christopher A Cassa; Rachel A Miller; Kenneth D Mandl
Journal:  J Am Med Inform Assoc       Date:  2012-11-02       Impact factor: 4.497

7.  The price of whole-genome sequencing may be decreasing, but who will be sequenced?

Authors:  Deborah A Marshall; Karen V MacDonald; Jill Oliver Robinson; Lisa F Barcellos; Milena Gianfrancesco; Monica Helm; Amy McGuire; Robert C Green; Michael P Douglas; Michael A Goldman; Kathryn A Phillips
Journal:  Per Med       Date:  2017-05-23       Impact factor: 2.512

Review 8.  Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals' knowledge and views, and ethical and legal concerns.

Authors:  Michelle Fernandes Martins; Logan T Murry; Liesl Telford; Frank Moriarty
Journal:  Eur J Hum Genet       Date:  2022-10-12       Impact factor: 5.351

9.  Use of complementary and alternative medicine and self-tests by coronary heart disease patients.

Authors:  Sheila Greenfield; Helen Pattison; Kate Jolly
Journal:  BMC Complement Altern Med       Date:  2008-08-04       Impact factor: 3.659

10.  Knowledge and attitude toward genetic diseases and genetic tests among pre-marriage individuals: A cross-sectional study in northern Iran.

Authors:  Mohammad Bagher Hashemi-Soteh; Ali Vali Nejad; Golamreza Ataei; Alireza Tafazoli; Dariush Ghasemi; Rita Siamy
Journal:  Int J Reprod Biomed       Date:  2019-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.